Financial Performance - Operating revenue for Q1 2024 was CNY 25,453,133.77, down 32.08% year-over-year from CNY 37,477,133.46[11] - Net profit attributable to shareholders for Q1 2024 was CNY 2,425,423.52, a decline of 61.04% compared to CNY 6,225,968.61 in the same period last year[11] - Total revenue for Q1 2024 was CNY 25,453,133.77, a decrease from CNY 37,477,133.46 in Q1 2023, representing a decline of approximately 32%[43] - Net profit for Q1 2024 was CNY 2,425,423.52, compared to CNY 6,225,968.61 in Q1 2023, reflecting a decrease of approximately 61%[44] - Basic and diluted earnings per share for Q1 2024 were CNY 0.0364, down from CNY 0.0934 in Q1 2023, reflecting a decline of approximately 61%[45] - The company reported a total comprehensive income of CNY 945,781.07 for Q1 2024, compared to CNY 917,946.35 in Q1 2023, reflecting a slight increase of 3.0%[47] Cash Flow - The company reported a net cash flow from operating activities of CNY -13,236,241.49, a slight increase of 0.61% compared to the previous year[13] - Cash flow from operating activities for Q1 2024 was negative at CNY -13,236,241.49, similar to CNY -13,155,842.87 in Q1 2023[49] - Cash flow from financing activities in Q1 2024 was CNY 10,559,981.25, a significant improvement compared to CNY -406,632.10 in Q1 2023[49] - The net cash flow from financing activities was $11.89 million, a significant increase compared to a negative cash flow of -$0.16 million previously[51] - The cash flow from operating activities showed a trend towards improvement despite remaining negative[51] Assets and Liabilities - Total assets as of March 31, 2024, were CNY 375,026,344.13, a decrease of 0.87% compared to the end of 2023[11] - The asset-liability ratio for the consolidated entity was 17.02%, a decrease from 17.61% at the end of 2023[11] - The company's total liabilities decreased to 63,826,962.23 CNY from 66,635,037.03 CNY, indicating a reduction of about 4.2%[38] - The company's equity attributable to shareholders was reported at 311,199,381.90 CNY, slightly down from 311,673,426.96 CNY[38] - Current liabilities rose to CNY 106,411,731.88 in Q1 2024, compared to CNY 102,940,589.49 in Q1 2023, marking an increase of approximately 3%[42] Shareholder Information - The largest shareholder, Wang Zhen, holds 22,836,026 shares, representing 34.25% of total shares[20] - The total shares held by the top ten shareholders amount to 37,956,620, which is 56.93% of the total shares[20] - Li Longping has pledged 2,000,200 shares, with no judicially frozen shares reported[21] Share Repurchase Plans - The company has implemented three share repurchase plans, with the first plan involving a repurchase of between 300,000 and 500,000 shares at a maximum price of 12.55 CNY per share[25][27] - The estimated total funds for the first repurchase plan range from 7.494 million to 12.49 million CNY[27] - The second repurchase plan also targets 300,000 to 500,000 shares with a similar funding estimate[28] - The third repurchase plan aims for the same number of shares, with an estimated total fund range of 3.765 million to 6.275 million CNY[28] - The implementation period for the share repurchase is set for up to six months from the board's approval[29] - The company aims to use repurchased shares for employee stock incentives and to stabilize stock prices[26] - The company repurchased a total of 1,300,469 shares, accounting for 1.95% of the total share capital, and 86.70% of the planned repurchase amount[30] - The highest transaction price for the repurchased shares was 12.85 CNY per share, while the lowest was 8.02 CNY per share, with a total payment of 18,203,560.20 CNY[30] Operating Costs - The company experienced a 37.41% decrease in operating costs, amounting to CNY 13,399,989.08, due to reduced revenue[13] - Total operating costs for Q1 2024 were CNY 23,880,872.56, down from CNY 32,028,808.68 in Q1 2023, indicating a reduction of about 25%[43] - Total operating expenses in Q1 2024 were CNY 44,206,053.96, compared to CNY 56,191,668.78 in Q1 2023, indicating a reduction of about 21.4%[48] Research and Development - Research and development expenses for Q1 2024 were CNY 5,056,388.61, up from CNY 4,724,880.51 in Q1 2023, indicating an increase of approximately 7%[43] - Research and development expenses for Q1 2024 were CNY 1,422,294.90, compared to CNY 1,410,674.08 in Q1 2023, showing a marginal increase of 0.8%[46] Legal and Compliance - No significant legal disputes or external guarantees have been reported during the reporting period[24] - The company has no intangible assets pledged as collateral, indicating a low risk in terms of asset encumbrance[32]
欧普泰(836414) - 2024 Q1 - 季度财报